Agostino Gemelli Polyclinic
Rome, Roma (provincia), 00168, Italy
NCT Number: NCT05883891
Alcoholic hepatitis (AH) is the most severe form of acute alcohol-related liver disease. Maddrey's discriminant function (mDF) >32 defines the severe form of AH, which is associated with a high mortality. Corticosteroid therapy (CS) represents the main medical treatment that may reduce short-term mortality. Lille score at day 7 assesses the therapeutic response to steroid therapy. At present, no parameters able to predict the response to steroid therapy have been highlighted. The mDF depends mainly on prothrombin time (PT). Aim of the present study was to evaluate if the PT value could predict the response to CS in severe AH (sAH).
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Rome, Roma (provincia), 00168, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Prothrombin time at value at diagnosis was used to assess the presence of a correlation with Lille score at day 7 and therefore wether it could predict response to medical treatment.
Time frame: seven days
response to standard medical treatment assessed with Lille scoremat day 7
Time frame: 28 days
death occurring during hospitalization from any cause
Time frame: 7 days
early transplantation in case of failure of medical treatment
Time frame: 28 days
occurrence of opportunistic infections following steroid treatment
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Acronym: AH2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03775109
Alcohol-Induced Disorders, Alcohol-Related Disorders
Bristol, United Kingdom
View Trial DetailsNCT02326103
Alcohol-Induced Disorders, Alcohol-Related Disorders
Helsinki, Finland
View Trial DetailsNCT00388323
Alcohol-Induced Disorders, Alcohol-Related Disorders
Clamart, France
View Trial DetailsNCT01476995
Acute Kidney Injury, Acute Renal Failure
Baltimore, Maryland, United States
View Trial Details